Page last updated: 2024-10-30

leflunomide and Complications of Diabetes Mellitus

leflunomide has been researched along with Complications of Diabetes Mellitus in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
"Cases of toxic neuropathy have been observed during treatment of rheumatoid arthritis with leflunomide."3.74Peripheral neuropathy associated with leflunomide: is there a risk patient profile? ( Bentaberry, F; Dehais, J; Dumoulin, C; Haramburu, F; Martin, K; Miremont-Salamé, G; Schaeverbeke, T, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martin, K1
Bentaberry, F1
Dumoulin, C1
Miremont-Salamé, G1
Haramburu, F1
Dehais, J1
Schaeverbeke, T1

Other Studies

1 other study available for leflunomide and Complications of Diabetes Mellitus

ArticleYear
Peripheral neuropathy associated with leflunomide: is there a risk patient profile?
    Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Complications;

2007
chemdatabank.com